Nu Skin Enterprises (NYSE:NUS) Releases Q2 2024 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) issued an update on its second quarter 2024 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 0.100-0.200 for the period, compared to the consensus earnings per share estimate of 0.340. The company issued revenue guidance of $420.0 million-$455.0 million, compared to the consensus revenue estimate of $453.0 million. Nu Skin Enterprises also updated its FY 2024 guidance to 0.950-1.350 EPS.

Nu Skin Enterprises Stock Up 1.4 %

Shares of NYSE NUS traded up $0.17 during mid-day trading on Wednesday, reaching $12.42. The company had a trading volume of 497,616 shares, compared to its average volume of 726,635. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.28 and a current ratio of 2.13. Nu Skin Enterprises has a twelve month low of $11.73 and a twelve month high of $38.23. The stock’s 50 day moving average is $12.65 and its 200-day moving average is $15.91. The stock has a market capitalization of $613.80 million, a PE ratio of 69.00 and a beta of 1.13.

Nu Skin Enterprises (NYSE:NUS) last issued its earnings results on Wednesday, February 14th. The company reported $0.37 EPS for the quarter, beating analysts’ consensus estimates of $0.29 by $0.08. Nu Skin Enterprises had a return on equity of 10.73% and a net margin of 0.44%. The firm had revenue of $488.64 million for the quarter, compared to the consensus estimate of $479.35 million. As a group, equities analysts anticipate that Nu Skin Enterprises will post 1.13 earnings per share for the current fiscal year.

Nu Skin Enterprises Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 6th. Stockholders of record on Monday, February 26th were issued a dividend of $0.06 per share. The ex-dividend date of this dividend was Friday, February 23rd. This represents a $0.24 dividend on an annualized basis and a dividend yield of 1.93%. Nu Skin Enterprises’s dividend payout ratio is currently 133.34%.

Wall Street Analyst Weigh In

Separately, StockNews.com cut Nu Skin Enterprises from a buy rating to a hold rating in a research report on Saturday, February 24th. Four analysts have rated the stock with a hold rating, According to MarketBeat, the company has a consensus rating of Hold and a consensus target price of $23.67.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.